AAAAAA

   
Results: 1-7 |
Results: 7
Reduced-intensity conditioning reduces the risk of severe infections afterallogeneic peripheral blood stem cell transplantation
Authors: Martino, R Caballero, MD Canals, C San Miguel, J Sierra, J Rovira, M Solano, C Bargay, J Perez-Simon, J Leon, A Sarra, J Brunet, S de la Camara, R
Citation: R. Martino et al., Reduced-intensity conditioning reduces the risk of severe infections afterallogeneic peripheral blood stem cell transplantation, BONE MAR TR, 28(4), 2001, pp. 341-347
Initial empiric therapy of febrile neutropenia with antibiotic monotherapy. Piperacillin/tazobactam versus imipenem/cilastatin (1994-1996)
Authors: Figuera, R Rivero, N Pajuelo, F Font, P Leyra, F de la Camara, R Arranz, R Ranada, JMF
Citation: R. Figuera et al., Initial empiric therapy of febrile neutropenia with antibiotic monotherapy. Piperacillin/tazobactam versus imipenem/cilastatin (1994-1996), MED CLIN, 116(16), 2001, pp. 610-611
Disparity for the minor histocompatibility antigen HA-1 is associated withan increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation
Authors: Gallardo, D Arostegui, JI Balas, A Torres, A Caballero, D Carreras, E Brunet, S Jimenez, A Mataix, R Serrano, D Vallejo, C Sanz, G Solano, C Rodriguez-Luaces, M Marin, J Baro, J Sanz, C Roman, J Gonzalez, M Martorell, J Sierra, J Martin, C de la Camara, R Granena, A
Citation: D. Gallardo et al., Disparity for the minor histocompatibility antigen HA-1 is associated withan increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation, BR J HAEM, 114(4), 2001, pp. 931-936
Hematopoietic cell transplantation in acute lymphoblastic leukemia: betterlong-term event-free survival with conditioning regimens containing total body irradiation
Authors: Granados, E de la Camara, R Madero, L Diaz, MA Martin-Regueira, P Steegmann, JL Arranz, R Figuera, A Fernandez-Ranada, JM
Citation: E. Granados et al., Hematopoietic cell transplantation in acute lymphoblastic leukemia: betterlong-term event-free survival with conditioning regimens containing total body irradiation, HAEMATOLOG, 85(10), 2000, pp. 1060-1067
Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome
Authors: de la Camara, R Martino, R Granados, E Rodriguez-Salvanes, FJ Rovira, M Cabrera, R Lopez, J Parody, R Sierra, J Fernandez-Ranada, JM Carreras, E
Citation: R. De La Camara et al., Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome, BONE MAR TR, 26(3), 2000, pp. 291-298
Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation
Authors: Steegmann, JL Casado, LF Tomas, JF Sanz-Rodriguez, C Granados, E de la Camara, R Alegre, A Vazquez, L Ferro, MT Figuera, A Arranz, L Fernandez-Ranada, JM
Citation: Jl. Steegmann et al., Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation, BONE MAR TR, 23(5), 1999, pp. 483-488
Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir?
Authors: de la Camara, R Fernandez-Ranada, JM
Citation: R. De La Camara et Jm. Fernandez-ranada, Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir?, J INFEC DIS, 180(2), 1999, pp. 571-572
Risultati: 1-7 |